Skip to main content
Premium Trial:

Request an Annual Quote

Avantra, MedTrust Online Ink MDx Partnership

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Avantra Biosciences and MedTrust Online today announced that they will collaborate on involving physicians in early-stage development of molecular diagnostic assays to run on Avantra's QPDx multiplex system.

Under the deal, the firms plan to provide more than 10,000 physicians with protein biomarkers implicated in a variety of cancers. As Avantra identifies biomarkers of interest, MedTrust will use its Knowledge Medicine platform to engage oncologists in online discussions that will validate the role of different panels in diagnosis, prognosis, and treatment efficacy.

Woburn, Mass.-based Avantra recently launched its Q400 Biomarker Workstation and AngioGenQx BioChip immunoassay. The firm said the system provides quantitative protein biomarker results for 10 analytes in less than an hour, with only five minutes required for sample preparation.

Avantra said that it plans to develop assays for ovarian, pancreatic, lung, prostate, breast, and colorectal cancers. It also is exploring the potential development of assays for infectious diseases, including an upcoming panel for sepsis.

"This partnership will provide cancer doctors with powerful biomarker assays that can be validated with clinical insights about their utility at the point of care," MedTrust CEO Christopher Yoo said in a statement. "The result of this joint effort will be better decisions based on the most accurate molecular knowledge available about an individual patient's disease."

Financial and other terms of the alliance were not disclosed.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.